Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis

Journal of Cell Biology

Volumn 192, Issue 1, 2011, Pages 55-67

  Hartig, Sean M ^a   He, Bin ^a   Long, Weiwen ^a   Buehrer, Benjamin M ^b   Mancini, Michael A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Zen Bio Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DEXAMETHASONE; HUMAN INSULIN; ISOBUTYLMETHYLXANTHINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR RECEPTOR COACTIVATOR 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; SMALL INTERFERING RNA; STEROID RECEPTOR COACTIVATOR 3;

ADIPOCYTE; ADIPOGENESIS; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; ENZYME PHOSPHORYLATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LENTIVIRINAE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS PARTICLE;

ADIPOCYTES; ADIPOGENESIS; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HOMEOSTASIS; HUMANS; IMAGING, THREE-DIMENSIONAL; LIPOGENESIS; NUCLEAR RECEPTOR COACTIVATOR 2; NUCLEAR RECEPTOR COACTIVATOR 3; PHENOTYPE; PHOSPHORYLATION; PPAR GAMMA; PROTEIN BINDING; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 78651329138     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.201004026     Document Type: Article

References (50)

1. Adams, M., M.J. Reginato, D.L. Shao, M.A. Lazar, and V.K. Chatterjee. 1997. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272:5128-5132. doi:10.1074/jbc.272.43.27295
2. Amazit, L., L. Pasini, A.T. Szafran, V. Berno, R.C. Wu, M. Mielke, E.D. Jones, M.G. Mancini, C.A. Hinojos, B.W. O'Malley, and M.A. Mancini. 2007. Regulation of SRC-3 intercompartmental dynamics by estrogen receptor and phosphorylation. Mol. Cell. Biol. 27:6913-6932. doi:10.1128/MCB.01695-06
3. Anzick, S.L., J. Kononen, R.L. Walker, D.O. Azorsa, M.M. Tanner, X.Y. Guan, G. Sauter, O.P. Kallioniemi, J.M. Trent, and P.S. Meltzer. 1997. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 277:965-968. doi:10.1126/science.277.5328.965
4. Camp, H.S., and S.R. Tafuri. 1997. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase. J. Biol. Chem. 272:10811-10816. doi:10.1074/jbc.272.16.10811
5. Chusainow, J., P.M. Ajuh, L. Trinkle-Mulcahy, J.E. Sleeman, J. Ellenberg, and A.I. Lamond. 2006. FRET analyses of the U2AF complex localize the U2AF35/U2AF65 interaction in vivo and reveal a novel self-interaction of U2AF35. RNA. 11:1201-1214. doi:10.1261/rna.7277705
6. Coste, A., J.F. Louet, M. Lagouge, C. Lerin, M.C. Antal, H. Meziane, K. Schoonjans, P. Puigserver, B.W. O'Malley, and J. Auwerx. 2008. The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1alpha. Proc. Natl. Acad. Sci. USA. 105:17187-17192. doi:10.1073/pnas.0808207105
7. Farmer, S.R. 2006. Transcriptional control of adipocyte formation. Cell Metab. 4:263-273. doi:10.1016/j.cmet.2006.07.001
8. Feige, J.N., L. Gelman, C. Tudor, Y. Engelborghs, W. Wahli, and B. Desvergne. 2005. Fluorescence imaging reveals the nuclear behavior of peroxisome proliferator-activated receptor/retinoid X receptor heterodimers in the absence and presence of ligand. J. Biol. Chem. 280:17880-17890. doi:10.1074/jbc. M500786200
9. Forman, B.M., P. Tontonoz, J. Chen, R.P. Brun, B.M. Spiegelman, and R.M. Evans. 1995. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell. 83:803-812. doi:10.1016/0092-8674(95)90193-0
10. Gelman, L., G. Zhou, L. Fajas, E. Raspé, J.C. Fruchart, and J. Auwerx. 1999. p300 interacts with the N- and C-terminal of PPARgamma2 in a ligand-independent and -dependent manner. J. Biol. Chem. 274:7681-7688. doi:10.1074/jbc.274.12.7681
11. Grimaldi, B., M.M. Bellet, S. Katada, G. Astarita, J. Hirayama, R.H. Amin, J.G. Granneman, D. Piomelli, T. Leff, and P. Sassone-Corsi. 2010. PER2 controls lipid metabolism by direct regulation of PPARγ. Cell Metab. 12:509-520. doi:10.1016/j.cmet.2010.10.005
12. Hong, H., K. Kohli, M.J. Garabedian, and M.R. Stallcup. 1997. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol. Cell. Biol. 17:2735-2744.
13. Hu, E.D., J.B. Kim, P. Sarraf, and B.M. Spiegelman. 1996. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science. 274:2100-2103. doi:10.1126/science.274.5295.2100
14. Kliewer, S.A., J.M. Lenhard, T.M. Willson, I. Patel, D.C. Morris, and J.M. Lehmann. 1995. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell. 83:813-819. doi:10.1016/0092-8674(95)90194-9
15. Kodera, Y., K. Takeyama, A. Murayama, M. Suzawa, Y. Masuhiro, and S. Kato. 2000. Ligand type-specific interactions of peroxisome proliferator- activated receptor gamma with transcriptional coactivators. J. Biol. Chem. 275:33201-33204. doi:10.1074/jbc.C000517200
16. Lavinsky, R.M., K. Jepsen, T. Heinzel, J. Torchia, T.M. Mullen, R. Schiff, A.L. Del-Rio, M. Ricote, S. Ngo, J. Gemsch, et al. 1998. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl. Acad. Sci. USA. 95:2920-2925. doi:10.1073/pnas.95.6.2920
17. Le, T.T., and J.X. Cheng. 2009. Single-cell profiling reveals the origin of phenotypic variability in adipogenesis. PLoS One. 4:e5189. doi:10.1371/journal.pone.0005189
18. Lodrini, M., T. Münz, N. Coudevylle, C. Griesinger, S. Becker, and E. Pfitzner. 2008. P160/SRC/NCoA coactivators form complexes via specific interaction of their PAS-B domain with the CID/AD1 domain. Nucleic Acids Res. 36:1847-1860. doi:10.1093/nar/gkn029
19. Loo, L.H., H.J. Lin, D.K. Singh, K.M. Lyons, S.J. Altschuler, and L.F. Wu. 2009. Heterogeneity in the physiological states and pharmacological responses of differentiating 3T3-L1 preadipocytes. J. Cell Biol. 187:375-384. doi:10.1083/jcb.200904140
20. Louet, J.F., and B.W. O'Malley. 2007. Coregulators in adipogenesis: what could we learn from the SRC (p160) coactivator family? Cell Cycle. 6:2448-2452. doi:10.4161/cc.6.20.4777
21. Louet, J.F., A. Coste, L. Amazit, M. Tannour-Louet, R.C. Wu, S.Y. Tsai, M.J. Tsai, J. Auwerx, and B.W. O'Malley. 2006. Oncogenic steroid receptor coactivator-3 is a key regulator of the white adipogenic program. Proc. Natl. Acad. Sci. USA. 103:17868-17873. doi:10.1073/pnas.0608711103
22. Mark, M., H. Yoshida-Komiya, M. Gehin, L. Liao, M.J. Tsai, B.W. O'Malley, P. Chambon, and J.M. Xu. 2004. Partially redundant functions of SRC-1 and TIF2 in postnatal survival and male reproduction. Proc. Natl. Acad. Sci. USA. 101:4453-4458. doi:10.1073/pnas.0400234101
23. McDonough, P.M., R.M. Agustin, R.S. Ingermanson, P.A. Loy, B.M. Buehrer, J.B. Nicoll, N.L. Prigozhina, I. Mikic, and J.H. Price. 2009. Quantification of lipid droplets and associated proteins in cellular models of obesity via high-content/high-throughput microscopy and automated image analysis. Assay Drug Dev. Technol. 7:440-460. doi:10.1089/adt.2009.0196
24. McInerney, E.M., D.W. Rose, S.E. Flynn, S. Westin, T.M. Mullen, A. Krones, J. Inostroza, J. Torchia, R.T. Nolte, N. Assa-Munt, et al. 1998. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev. 12:3357-3368. doi:10.1101/gad.12.21.3357
25. McKenna, N.J., Z. Nawaz, S.Y. Tsai, M.J. Tsai, and B.W. O'Malley. 1998. Distinct steady-state nuclear receptor coregulator complexes exist in vivo. Proc. Natl. Acad. Sci. USA. 95:11697-11702. doi:10.1073/pnas.95.20.11697
26. Michalik, L., J. Auwerx, J.P. Berger, V.K. Chatterjee, C.K. Glass, F.J. Gonzalez, P.A. Grimaldi, T. Kadowaki, M.A. Lazar, S. O'Rahilly, et al. 2006. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol. Rev. 58:726-741. doi:10.1124/pr.58.4.5
27. Molnár, F., M. Matilainen, and C. Carlberg. 2005. Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators. J. Biol. Chem. 280:26543-26556. doi:10.1074/jbc.M502463200
28. Nolte, R.T., G.B. Wisely, S. Westin, J.E. Cobb, M.H. Lambert, R. Kurokawa, M.G. Rosenfeld, T.M. Willson, C.K. Glass, and M.V. Milburn. 1998. Ligand binding and co-activator assembly of the peroxisome proliferator- activated receptor-gamma. Nature. 395:137-143. doi:10.1038/25931
29. Oñate, S.A., S.Y. Tsai, M.J. Tsai, and B.W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 270:1354-1357. doi:10.1126/science.270.5240.1354
30. Picard, F., M. Géhin, J.S. Annicotte, S. Rocchi, M.F. Champy, B.W. O'Malley, P. Chambon, and J. Auwerx. 2002. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell. 111:931-941. doi:10.1016/S0092-8674(02)01169-8
31. Rangwala, S.M., B. Rhoades, J.S. Shapiro, A.S. Rich, J.K. Kim, G.I. Shulman, K.H. Kaestner, and M.A. Lazar. 2003. Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity. Dev. Cell. 5:657-663. doi:10.1016/S1534-5807(03)00274-0
32. Reginato, M.J., S.T. Bailey, S.L. Krakow, C. Minami, S. Ishii, H. Tanaka, and M.A. Lazar. 1998. A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor gamma-activating properties. J. Biol. Chem. 273:32679-32684. doi:10.1074/jbc.273.49.32679
33. Rocchi, S., F. Picard, J. Vamecq, L. Gelman, N. Potier, D. Zeyer, L. Dubuquoy, P. Bac, M.F. Champy, K.D. Plunket, et al. 2001. A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol. Cell. 8:737-747. doi:10.1016/S1097-2765(01)00353-7
34. Rosen, E.D., P. Sarraf, A.E. Troy, G. Bradwin, K. Moore, D.S. Milstone, B.M. Spiegelman, and R.M. Mortensen. 1999. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell. 4:611-617. doi:10.1016/S1097-2765(00)80211-7
35. Rosen, E.D., C.H. Hsu, X.Z. Wang, S. Sakai, M.W. Freeman, F.J. Gonzalez, and B.M. Spiegelman. 2002. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 16:22-26. doi:10.1101/gad.948702
36. Shao, D.L., S.M. Rangwala, S.T. Bailey, S.L. Krakow, M.J. Reginato, and M.A. Lazar. 1998. Interdomain communication regulating ligand binding by PPAR-gamma. Nature. 396:377-380. doi:10.1038/24634
37. Stenoien, D.L., M.G. Mancini, K. Patel, E.A. Allegretto, C.L. Smith, and M.A. Mancini. 2000. Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1. Mol. Endocrinol. 14:518-534. doi:10.1210/me.14.4.518
38. Stenoien, D.L., M. Mielke, and M.A. Mancini. 2002. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components. Nat. Cell Biol. 4:806-810. doi:10.1038/ncb859
39. Szafran, A.T., M. Szwarc, M. Marcelli, and M.A. Mancini. 2008. Androgen receptor functional analyses by high throughput imaging: determination of ligand, cell cycle, and mutation-specific effects. PLoS One. 3:e3605. doi:10.1371/journal.pone.0003605
40. Szafran, A.T., S.M. Hartig, H. Sun, I.P. Uray, M. Szwarc, Y. Shen, S.N. Mediwala, J. Bell, M.J. McPhaul, M.A. Mancini, and M. Marcelli. 2009. Androgen receptor mutations associated with androgen insensitivity syndrome: a high content analysis approach leading to personalized medicine. PLoS One. 4:e8179. doi:10.1371/journal.pone.0008179
41. Trinkle-Mulcahy, L., J.E. Sleeman, and A.I. Lamond. 2001. Dynamic targeting of protein phosphatase 1 within the nuclei of living mammalian cells. J. Cell Sci. 114:4219-4228.
42. Tsai, Y.S., P.J. Tsai, M.J. Jiang, T.Y. Chou, A. Pendse, H.S. Kim, and N. Maeda. 2009. Decreased PPAR gamma expression compromises perigonadal-specific fat deposition and insulin sensitivity. Mol. Endocrinol. 23:1787-1798. doi:10.1210/me.2009-0073
43. Tudor, C., J.N. Feige, H. Pingali, V.B. Lohray, W. Wahli, B. Desvergne, Y. Engelborghs, and L. Gelman. 2007. Association with coregulators is the major determinant governing peroxisome proliferator-activated receptor mobility in living cells. J. Biol. Chem. 282:4417-4426. doi:10.1074/jbc.M608172200
44. Wang, Z.Y., C. Qi, A. Krones, P. Woodring, X.Y. Zhu, J.K. Reddy, R.M. Evans, M.G. Rosenfeld, and T. Hunter. 2006. Critical roles of the p160 transcriptional coactivators p/CIP and SRC-1 in energy balance. Cell Metab. 3:111-122. doi:10.1016/j.cmet.2006.01.002
45. Wu, Z.D., N.L.R. Bucher, and S.R. Farmer. 1996. Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids. Mol. Cell. Biol. 16:4128-4136.
46. Wu, Z.D., E.D. Rosen, R. Brun, S. Hauser, G. Adelmant, A.E. Troy, C. McKeon, G.J. Darlington, and B.M. Spiegelman. 1999. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell. 3:151-158. doi:10.1016/S1097-2765(00)80306-8
47. Xu, J., R.C. Wu, and B.W. O'Malley. 2009. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat. Rev. Cancer. 9:615-630. doi:10.1038/nrc2695
48. Yeh, W.C., Z.D. Cao, M. Classon, and S.L. McKnight. 1995. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 9:168-181. doi:10.1101/gad.9.2.168
49. Zhang, H., X. Yi, X.J. Sun, N. Yin, B. Shi, H.J. Wu, D. Wang, G. Wu, and Y.F. Shang. 2004. Differential gene regulation by the SRC family of coactivators. Genes Dev. 18:1753-1765. doi:10.1101/gad.1194704
50. Zuo, Y., L. Qiang, and S.R. Farmer. 2006. Activation of CCAAT/enhancer-binding protein (C/EBP) alpha expression by C/EBP beta during adipogenesis requires a peroxisome proliferator-activated receptor-gamma- associated repression of HDAC1 at the C/ebp alpha gene promoter. J. Biol. Chem. 281:7960-7967. doi:10.1074/jbc.M510682200